Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP594335.RAHpzvRhG3sTtrJ4SuCXRX6rNWnUZe5zXTY3dWS0NSCT8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP594335.RAHpzvRhG3sTtrJ4SuCXRX6rNWnUZe5zXTY3dWS0NSCT8130_assertion type Assertion NP594335.RAHpzvRhG3sTtrJ4SuCXRX6rNWnUZe5zXTY3dWS0NSCT8130_head.
- NP594335.RAHpzvRhG3sTtrJ4SuCXRX6rNWnUZe5zXTY3dWS0NSCT8130_assertion description "[The reduction of ADARB2 correlated with the grade of malignancy of glioblastoma multiforme, the most aggressive of brain tumors, displaying a 99% decrease in ADARB2 RNA levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP594335.RAHpzvRhG3sTtrJ4SuCXRX6rNWnUZe5zXTY3dWS0NSCT8130_provenance.
- NP594335.RAHpzvRhG3sTtrJ4SuCXRX6rNWnUZe5zXTY3dWS0NSCT8130_assertion evidence source_evidence_literature NP594335.RAHpzvRhG3sTtrJ4SuCXRX6rNWnUZe5zXTY3dWS0NSCT8130_provenance.
- NP594335.RAHpzvRhG3sTtrJ4SuCXRX6rNWnUZe5zXTY3dWS0NSCT8130_assertion SIO_000772 17908822 NP594335.RAHpzvRhG3sTtrJ4SuCXRX6rNWnUZe5zXTY3dWS0NSCT8130_provenance.
- NP594335.RAHpzvRhG3sTtrJ4SuCXRX6rNWnUZe5zXTY3dWS0NSCT8130_assertion wasDerivedFrom befree-20140225 NP594335.RAHpzvRhG3sTtrJ4SuCXRX6rNWnUZe5zXTY3dWS0NSCT8130_provenance.
- NP594335.RAHpzvRhG3sTtrJ4SuCXRX6rNWnUZe5zXTY3dWS0NSCT8130_assertion wasGeneratedBy ECO_0000203 NP594335.RAHpzvRhG3sTtrJ4SuCXRX6rNWnUZe5zXTY3dWS0NSCT8130_provenance.